Navigation Links
'TUG' Procedure by Texas Health Dallas Cardiologist Offers Hope to Millions of Patients
Date:6/9/2009

DALLAS, June 9 /PRNewswire-USNewswire/ -- Interventional cardiac catheterization procedures are one of the most effective treatments for peripheral vascular disease (PVD), a looming health crisis as the U.S. population ages and more Americans battle obesity. But the procedures are not an option for millions of Americans with PVD who also have kidney problems or allergies to the contrast dye used during the procedures.

As a possible new option for these patients, Dr. Tony Das, an interventional cardiologist at Texas Health Presbyterian Hospital Dallas, recently demonstrated a unique procedure that clears femoral artery blockages without the use of contrast dye or X-ray radiation.

"We're always looking for new and innovative ways to better care for patients with this debilitating condition," Dr. Das said. "This procedure could one day be something we offer people who are not suitable candidates for other interventional procedures."

Called TUG (transcutaneous ultrasound guided vascular intervention), the procedure involves using an ultrasound device on top of the patient's skin to produce images of the arteries and guide a tiny wire that travels inside the arteries to clear the blockage. A balloon on the end of the wire is inflated to open the artery and a stent placed in the artery to keep it open.

"With the prevalence of diabetes and obesity among an already aging population, the challenges facing those involved in the diagnosis and treatment of peripheral vascular disease increase by the minute," Dr. Das said. "It's a problem that will increasingly challenge medical experts around the country in coming years."

PVD is a common condition affecting more than 10 million adults in the United States. The condition is a disease of blood vessels outside the heart and brain characterized by a narrowing of vessels that carry blood to the legs, arms, stomach and kidneys. The condition causes lower-leg tissue damage, non-healing wounds, blood clots and limb loss.

"Currently, PVD patients with kidney problems or allergies to contrast dye can only be treated with medications or open surgery, which carries a higher risk for complications," said Jon Gardner, administrative director of the Heart & Vascular Service Line at Texas Health Dallas. "Innovative new procedures like Dr. Das' technique could provide hope to these patients."


'/>"/>
SOURCE Texas Health Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Top Book on Cosmetic Surgery Anesthesia to be Released in Portuguese in Brazil, World Leader in Cosmetic Surgery
2. Varian Medical Systems Introduces Fast and Precise Brachytherapy Planning System at GEC-ESTRO in Portugal
3. Misonix Announces New HIFU Distribution Agreement For Portugal
4. Misonix Announces New Distribution Agreement for Portugal
5. Portuguese scientists discover new mechanism that regulates formation of blood vessels
6. Chiltern Announces New Expansion in Portugal
7. Tug of war in the cells
8. The Tug McGraw Foundation Announces 2007 Fundraising Gala
9. Survey Reveals Injectable Procedures Are Mainstream And Accepted Medical Aesthetic Treatment Options
10. Kenneth L. Reed, M.D. Performs First State of the Art AccuraScope(TM) Procedure in Dallas
11. Abbotts XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, Real World Patients in SPIRIT V Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... 06, 2016 , ... The Behavioral Health Center of Excellence ... organization as a top behavioral service provider in the country. The award celebrates ... satisfaction and qualifications, and consumer satisfaction. These areas are measured via a wide-ranging ...
(Date:12/6/2016)... Cary, NC (PRWEB) , ... December 06, 2016 ... ... cancer research charity, is thrilled to formally announce its Not a Moment to ... Moment to Lose will rally supporters dedicated to declaring victory over cancer. The ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... is now offering HIAC particle counting and sizing services for USP 788 and ... instituted the new service as a response to the needs of pharmaceutical and ...
(Date:12/6/2016)... ... 06, 2016 , ... METTLER TOLEDO has launched its online ... white papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, brochures, datasheets, user ... documents, webinars and videos available online, visit the METTLER TOLEDO Expertise Library ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble ... Featuring one of the world’s most powerful antioxidants, molecular hydrogen, HydroFX for ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... NEW YORK , Dec. 5, 2016 /PRNewswire/ ... of penicillin in 1948, antibiotics have emerged as ... treating several infectious conditions. In addition, antibiotics are ... have undergone surgery, or immunocompromised patients (cancer patients ... both in healthcare and food production, has rapidly ...
(Date:12/5/2016)... 29, 2016 Several leading Alzheimer,s disease experts ... Inc. at 11 a.m. EST on December 6 ... Clinical Trials for Alzheimer,s Disease (CTAD). The program will ... disease and therapeutic targets that address deficient glucose metabolism ... recent failure of another therapy targeting the amyloid hypothesis, ...
(Date:12/5/2016)... Research and Markets has announced the addition of the ... Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & ... offering. ... The western blotting market is expected ... in 2016, growing at a CAGR of 4.9%. ...
Breaking Medicine Technology: